share_log

Corcept Therapeutics | 8-K: CORCEPT THERAPEUTICS ANNOUNCES THIRD QUARTER FINANCIAL RESULTS, POSITIVE RESULTS FROM PHASE 3 GRADIENT TRIAL IN PATIENTS WITH CUSHING'S SYNDROME AND PROVIDES CORPORATE UPDATE

Corcept Therapeutics | 8-K: CORCEPT THERAPEUTICS ANNOUNCES THIRD QUARTER FINANCIAL RESULTS, POSITIVE RESULTS FROM PHASE 3 GRADIENT TRIAL IN PATIENTS WITH CUSHING'S SYNDROME AND PROVIDES CORPORATE UPDATE

Corcept醫療 | 8-K:Corcept THERAPEUTICS公佈了第三季度財務業績、針對庫欣綜合徵患者的3期GradiEN試驗的積極結果,並提供了公司最新情況
美股SEC公告 ·  10/31 04:13

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。